Research progress of CD+4 CD+25 Foxp3 Treg cells in the hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 237-240, 2008.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-472203
Responsible library:
WPRO
ABSTRACT
Thymus derived CD+4; CD+25 regulatory T cells (Treg) are thought to be specific T cells that play an important role in controlling autoimmunity, preventing transplant rejection, restraining anti-infectious immune response, suppressing allogeneic immune respons. More recently, these cells are reported to have the ability of suppressing antitumor immune response. Foxp3 are the most specific protein of Treg. In this review, we will discuss the expression of CD+4 CD+25 Treg in patients with hematological malignancies and its implication for immunotherapy.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2008
Document type:
Article